东当归对四氯化碳及乙醇性肝损伤的保护作用

研究东当归水提取物对四氯化碳及乙醇所致小鼠SGPT和SGOT活性升高的影响。在四氯化碳及乙醇所致小鼠急性肝损伤的血清中检测SGPT和SGOT值。结果表明,37．5％、75．0％和150．0％东当归水提物在体内显著抑制四氯化碳及乙醇所致小鼠SGPT值和／或SGOT值升高。东当归水提取物对小鼠四氯化碳及乙醇性肝损伤具有保护作用。     

茵栀黄注射液对四氯化碳和硫代乙酰胺致小鼠肝脏损伤的保护作用

目的 :研究茵栀黄注射液对四氯化碳 (CCl4 )和硫代乙酰胺 (TAA)所致小鼠肝脏损伤的保护作用。方法 :采用四氯化碳和硫代乙酰胺造成小鼠化学性损伤 ,观察茵栀黄注射液的保护作用。结果 :小鼠静脉注射茵栀黄注射液能明显降低CCl4 和TAA所致小鼠血清ALT和AST水平 ,并可显著改善小鼠肝损伤的病变程度。结论 :茵栀黄注射液对CCl4 和TAA所致小鼠肝损伤具有保护作用     

具有保肝作用的天然药物开发进展

肝脏是机体代谢的最主要场所,也是机体最容易遭受到损伤的脏器之一,各种因素引起的肝损伤已成为威胁人类健康的重要疾病之一。肝损伤机制主要与线粒体损伤、自由基脂质过氧化、炎症细胞因子分泌和细胞膜损伤有关。目前已报道很多天然药物具有显著保肝作用,且具有疗效稳定、副作用低、多途径作用、作用温和持久等优势,已广泛用于肝脏疾病的防治。本文对肝损伤的生理机制以及具有保肝作用的天然药物开发进展进行了综述,提出了目前存在的一些问题并进行了展望。     

蛹虫草MF27高抗氧化活性提取物筛选及保肝作用研究

本研究对一株优质蛹虫草菌株MF27不同提取物进行体外抗氧化活性比较,筛选得到高抗氧化活性提取物,并进一步探究该提取物对CCl₄诱导的小鼠肝损伤的修复作用。以DPPH自由基和羟自由基的清除率为抗氧化评价指标,从菌丝体发酵液、菌丝体水提物/醇提物、以及子实体水提物/醇提物中筛选菌株MF27的高抗氧化活性提取物;以CCl₄致小鼠急性肝损伤为模型,通过检测血清生化指标、肝功指标的变化,来评价该高活性提取物的体内抗氧化保肝效果。体外抗氧化实验结果表明,MF27的不同提取物均具有较好的体外抗氧化活性,但对清除DPPH和OH自由基能力最好的提取物是子实体水提物,其对DPPH自由基的半数有效浓度（EC₅₀）为0.096mg/mL,对羟自由基的半数有效浓度（EC₅₀）为0.196mg/mL,当在1mg/mL 时对DPPH自由基的清除率为94.94%,对羟自由基的清除率为70.17%;体内抗氧化保肝结果显示,给药组（子实体水提物）相比模型组而言,小鼠血清中ALT、AST以及肝脏中MDA水平极显著降低（P<0.01）、SOD水平极显著升高（P<0.01）,表明子实体水提物能有效改善氧化性肝损伤,同时与阳性对照（联苯双酯）对比,给药组在肝脏指数上表现出相当的作用（P>0.05）。本研究表明菌株MF27的最有效抗氧化活性提取物是子实体水提物,它对体内氧化性肝损伤有一定的修复能力,揭示MF27子实体水提物具有成为抗氧化性肝损伤功能产品的潜力。     

柴达木盆地唐古特白刺籽油保护肝损伤作用研究

对柴达木盆地唐古特白刺种籽油保护化学性肝损伤作用进行了研究.将小鼠按体重随机分为白刺籽油高、中、低剂量组,另设空白对照组和联苯双酯、藏茵陈阳性对照组.小鼠连续灌胃给药15 d后,用CCl4进行肝损伤,测定小鼠血清谷丙转氨酶（ALT）、谷草转氨酶（AST）;肝脏过氧化脂质（LPO）降解产物丙二醛（MDA）和谷胱甘肽过氧化物酶（GSH-Px）的含量.结果显示,白刺籽油对血清ALT、AST具有显著的抑制作用,显著拮抗肝脏MDA的升高,显著提高肝脏GSH-Px含量.表明白刺籽油具有明显的保护化学性肝损伤的保健作用.     

杭白菊的化学成分研究：两个新三萜酯的结构测定

从杭白菊(Dendranthema morifolium (Ramat. )Tzvel.)的乙醚部分分离出13个化合物。运用波谱技术和化学方法证明其中2个为新化合物,命名为棕榈酸16β,22α-二羟基假蒲公英甾醇酯(1)和棕榈酸16β,28-二羟基羽扇醇酯(2)。     

蟛蜞菊内酯对四氯化碳致小鼠肝损伤的保护作用

目的:研究中药活性物质蟛蜞菊内酯的保肝作用及其机制。方法:采用小鼠腹腔注射CCl4制作肝损伤模型,测定小鼠血清中谷丙转氨酶(ALT)、谷草转氨酶(AST)、丙二醛(MDA),谷胱甘肽(GSH)和超氧化物歧化酶(SOD)指标,进行肝脏的组织病理学检查,观察蟛蜞菊内酯对CCl4所致肝损伤的保护作用。结果:蟛蜞菊内酯能明显降低肝损伤小鼠的血清ALT、AST和肝组织匀浆中MDA含量,SOD活力增强,明显减轻肝组织变性。结论蟛蜞菊内酯对CCl4引起的肝损伤有明显的保护作用,其机制可能与其抗氧化作用有关。     

水飞蓟素对四氯化碳致小鼠肝损伤的保护作用

目的:探讨水飞蓟素对四氯化碳致(CCl4)小鼠肝损伤是否有保护作用。方法:60只ICR小鼠随机分为6组(n=10),正常组、模型组、联苯双酯阳性对照组,低、中、高剂量水飞蓟素组(100、200、400 mg/kg)。各组连续给药10 d,末次给药1 h后,正常组腹腔注射橄榄油,其余各组腹腔注射0.12%的CCl4橄榄油溶液,16 h后测定血清中丙氨基转移酶(ALT)和天门冬氨酸氨基转移酶(AST),肝浆中丙二醛(MDA),谷胱甘肽过氧化物酶(GSH-Px)和超氧化物岐化酶(SOD)的水平。结果:水飞蓟素各剂量组能显著的抑制肝损伤血清中ALT和AST的升高(P<0.05,P<0.01),亦能抑制肝组织中MDA的升高(P<0.01),增加肝组织中SOD的活性和GSH-Px的水平(P<0.05)。结论:水飞蓟素具有明显的四氯化碳致小鼠肝损伤的保护作用。     

贡菊黄酮抗小鼠急性肝损伤作用的研究

为研究黄山贡菊中黄酮的提取纯化方法及其抗小鼠急性肝损伤作用,采用乙醇回流法从黄山贡菊中提取粗黄酮,聚酰胺柱层析纯化,真空冷冻干燥获得黄酮粉末。对以四氯化碳造模的急性肝损伤小鼠分别给予联苯双酯及不同剂量的贡菊黄酮灌胃,测定血清中GPT/ALT、GOT/AST活性,测定肝组织中SOD活性和丙二醛含量,HE染色观察肝组织病理形态学的改变。结果表明,黄山贡菊黄酮可以降低急性肝损伤小鼠血清中GPT/ALT、GOT/AST活性,提高肝组织的SOD活性,降低丙二醛含量,对减轻肝脏病理组织损伤有积极作用。     

不同产地杭白菊多糖的含量测定

目的：建立杭白菊多糖的测定方法,比较不同产地杭白菊多糖含量的差异,为杭白菊的质量评价提供科学依据。方法：采用高锰酸钾滴定法测定浙江桐乡、江苏射阳等5个产地杭白菊多糖含量,并进行方法学考察。结果：杭白菊多糖的含量线性关系、精密度、重复性、回收率及稳定性测定结果均符合要求,不同产地杭白菊中多糖含量范围为5.27%~8.72%。结论：不同产地的杭白菊中多糖含量有一定差异,在评价的样本中,山东临沂地区杭白菊多糖含量最高。     

The Protective Effect of ENA Actimineral Resource A on CCl4-Induced Liver Injury in Rats

ENA Actimineral Resource A (ENA-A) is alkaline water that is composed of refined edible cuttlefish bone and two different species of seaweed, Phymatolithon calcareum and Lithothamnion corallioides. In the present study, ENA-A was investigated as an antioxidant to protect against CCl(4)-induced oxidative stress and hepatotoxicity in rats. Liver injury was induced by either subacute or chronic CCl(4) administration, and the rats had free access to tap water mixed with 0% (control group) or 10% (v/v) ENA-A for 5 or 8?weeks. The results of histological examination and measurement of antioxidant activity showed that the reactive oxygen species production, lipid peroxidation, induction of CYP2E1 were decreased and the antioxidant activity, including glutathione and catalase production, was increased in the ENA-A groups as compared with the control group. On 2-DE gel analysis of the proteomes, 13 differentially expressed proteins were obtained in the ENA-A groups as compared with the control group. Antioxidant proteins, including glutathione S-transferase, kelch-like ECH-associated protein 1, and peroxiredoxin 1, were increased with hepatocyte nuclear factor 3-beta and serum albumin precursor, and kininogen precursor decreased more in the ENA-A groups than compared to the control group. In conclusion, our results suggest that ENA-A does indeed have some protective capabilities against CCl(4)-induced liver injury through its antioxidant function.     

藻蓝蛋白复合物对酒精性肝损伤的保护作用

本文对藻蓝蛋白复合物保护化学性肝损伤的功效学进行了研究.以Wistar大鼠建立酒精性肝损伤模型,将藻蓝蛋白复合物分为高、中、低三个剂量组,以联苯双酯作为阳性对照组,灌胃给药42 d,分别测定血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、血清丙二醛(MDA)、谷胱甘肽(CSH)、肝匀浆丙二醛(MDA)和谷胱甘肽(GSH)的含量,并对肝脏切片进行病理检查.结果表明:藻蓝蛋白复合物对血清ALT、AST具有显著的抑制作用,显著拮抗肝脏MDA的升高,显著提高肝脏GSH-Px含量.出现肝细胞浊肿、脂肪变性、点状坏死的大鼠数目极少.从而表明藻蓝蛋白复合物具有显著的保护酒精性肝损伤的功效.     

Inhibitory Effect of Gallic Acid on CCl4-Mediated Liver Fibrosis in Mice

The aim of this study was to investigate the effect of gallic acid (GA) on liver fibrosis induced by carbon tetrachloride (CCl₄). Male BALB/c mice were randomly divided into four groups: normal control group (group A), CCl₄-induced liver injury control group (group B), and CCl₄ induction with GA of low dose (5 mg/kg) and high dose (15 mg/kg) treatment group (group C and group D). GA was intra-gastric given for mice once a day after 2 weeks of CCl₄ induction. Animals were killed at the eighth week. Degrees of fibrosis and collagen percentage were measured. Hyaluronic acid (HA), type IV collagen (cIV), malondialdehyde (MDA), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (γ-GT) were determined. Expression of matrix metalloproteinases-2 (MMP-2) and tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) mRNA levels were examined by RT-PCR. Western blotting was carried out to evaluate the changes of MMP-2 protein. HE and VG stainings showed GA in a dose-dependent manner improved significantly the fibrosis condition in CCl₄-injured mice (P < 0.05 or P < 0.01). Also, the concentrations of HA, cIV, and MDA, as well as the serum levels of ALT, AST, and γ-GT were markedly reduced by GA (P < 0.05 or P < 0.01), and decreases in MMP-2, TIMP-1 mRNA, and MMP-2 protein were observed as well (P < 0.05 or P < 0.01). GA could exert protective effect on liver injury and reduce liver fibrosis induced by CCl₄ in mice, which might be through the inhibition of hepatic stellate cell activity.     

The Protective Effect of Esculentoside A on Experimental Acute Liver Injury in Mice

Inflammatory response and oxidative stress are considered to play an important role in the development of acute liver injury induced by carbon tetrachloride (CCl₄) and galactosamine (GalN)/lipopolysaccharides (LPS). Esculentoside A (EsA), isolated from the Chinese herb phytolacca esculenta, has the effect of modulating immune response, cell proliferation and apoptosis as well as anti-inflammatory effects. The present study is to evaluate the protective effect of EsA on CCl₄ and GalN/LPS-induced acute liver injury. In vitro, CCK-8 assays showed that EsA had no cytotoxicity, while it significantly reduced levels of TNF-α and cell death rate challenged by CCl₄. Moreover, EsA treatment up-regulated PPAR-γ expression of LO2 cells and reduced levels of reactive oxygen species (ROS) challenged by CCl₄. In vivo, EsA prevented mice from CCl₄-induced liver histopathological damage. In addition, levels of AST and ALT were significantly decreased by EsA treatment. Furthermore, the mice treated with EsA had a lower level of TNF-α, Interleukin (IL)-1β and IL-6 in mRNA expression. EsA prevented MDA release and increased GSH-Px activity in liver tissues. Immunohistochemical staining showed that over-expression of F4/80 and CD11b were markedly inhibited by EsA. The western bolt results showed that EsA significantly inhibited CCl₄-induced phosphonated IkBalpha (P-IκB) and ERK. Furthermore, EsA treatment also alleviated GalN/LPS-induced acute liver injury on liver enzyme and histopathological damage. Unfortunately, our results exhibited that EsA had no effects on CCl₄-induced hepatocyte apoptosis which were showed by TUNEL staining and Bax, Caspase-3 and cleaved Caspase-3 expression. Our results proved that EsA treatment attenuated CCl₄ and GalN/LPS-induced acute liver injury in mice and its protective effects might be involved in inhibiting inflammatory response and oxidative stress, but not apoptosis with its underlying mechanism associated with PPAR-γ, NF-κB and ERK signal pathways.     

伤寒头对CCl_4致小鼠急性肝损伤的保护作用及其机理

本研究将健康昆明种小鼠36只,雌雄各半,随机分为空白对照组、模型组、药物联苯组、伤寒头高剂量、中剂量及低剂量组。各分组连续给药3d,末次给药1h后,除正常对照组外,其余各组腹腔注射1%CCl4花生油溶液0.1mL/10g建立小鼠急性肝损伤模型。测试小鼠禁食24h后,摘眼球取血并处死动物,分离血清进行血清生化指标的测定,检测小鼠血清中门冬氨酸氨基转氨酶(AST)、丙氨酸氨基转氨酶(ALT)、白蛋白(ALB)和总蛋白(TP)水平;剖检并取肝脏组织测肝脏重量,取部分肝组织研磨成匀浆测定超氧化物歧化酶(SOD),丙二醛(MDA)和谷胱甘肽过氧化物酶(GSH-PX)。观察伤寒头处理下小鼠血清中AST、ALT、ALB和TP以及肝脏中SOD、MDA和GSH-PX的变化。结果表明,各伤寒头治疗组对AST、ALT均有明显的降低作用(P0.01),对TP、ALB没有影响(P0.05);各伤寒头治疗组对SOD和GSH-PX有升高作用(P0.05),对MDA有降低作用(P0.05),对肝脏指数没有影响(P0.05)。根据本研究结果,我们推断伤寒头对四氯化碳所致小鼠急性肝损伤具有明显的保护作用,主要是通过提高SOD和GSH-PX酶的活性,降低MDA来达到保护肝脏的作用。     

Protective effects of selenium-glutathione-enriched probiotics on CCl4-induced liver fibrosis

Hepatic fibrosis is a common pathological basis of liver cirrhosis and hepatocellular carcinomas. So, prevention and treatment of liver fibrosis is one of the crucial therapeutic goals in hepatology. Organic selenium, glutathione or probiotics supplementation could ameliorate hepatic fibrosis, respectively. The purpose of this study is to develop a novel selenium-glutathione-enriched probiotics (SGP) and to investigate its protective effect on CCl₄-induced liver fibrosis in rats. Yeast strains with the high-yield glutathione were isolated and identified by analysis of 26S ribosomal DNA sequences. The fermentation parameters of SGP were optimized through single-factor, Plackett–Burman (PB) design and response surface methodology (RSM). The final SGP contained 38.4 μg/g of organic selenium, 34.1 mg/g of intracellular glutathione, approximately 1×10¹⁰ CFU/g live Saccharomyces cerevisiae and 1×10¹² CFU/g live Lactobacillus acidophilus. SGP had better protective effects on liver fibrosis than selenium, glutathione or probiotics, respectively. The hepatic silent information regulator 1 (SIRT1) level was down-regulated and oxidative stress, endoplasmic reticulum (ER) stress, inflammation and phosphorylated MAPK was increased in CCl₄-treated rats. However, SGP can significantly reverse these changes caused by CCl₄. Our findings suggest that SGP was effective in attenuating liver fibrosis by the activation of SIRT1 signaling and attenuating hepatic oxidative stress, ER stress, inflammation and MAPK signaling.     

Protective effects of L-carnosine on CCl4 -induced hepatic injury in rats

The present study was undertaken to investigate the possible protective effect of L-carnosine (CAR), an endogenous dipeptide of alanine and histidine, on carbon tetrachloride (CCl₄)-induced hepatic injury. Liver injury was induced in male Sprague-Dawley rats by intraperitoneal (i.p.) injections of CCl₄, twice weekly for six weeks. CAR was administered to rats daily, at dose of 250 mg/kg, i.p. At the end of six weeks, blood and liver tissue specimens were collected. Results show that CAR treatment attenuated the hepatic morphological changes, necroinflammation and fibrosis induced by CCl₄, as indicated by hepatic histopathology scoring. In addition, CAR treatment significantly reduced the CCl₄-induced elevation of liver-injury parameters in serum. CAR treatment also combated oxidative stress; possibly by restoring hepatic nuclear factor erythroid 2-related factor 2 (Nrf-2) levels. Moreover, CAR treatment prevented the activation of hepatic stellate cells (HSCs), as indicated by reduced α-smooth muscle actin (α-SMA) expression in the liver, and decreased hepatic inflammation as demonstrated by a reduction in hepatic tumor necrosis factor-α (TNF-α) and restoration of interleukin-10 (IL-10) levels. In conclusion, CCl₄-induced hepatic injury was alleviated by CAR treatment. The results suggest that these beneficial, protective effects are due, at least in part, to its anti-oxidant, anti-inflammatory and anti-fibrotic activities.     

Hepatoprotective Effect of Manganese Chloride Against CCl4-Induced Liver Injury in Rats

The aim of the present study is to evaluate the protective effect of manganese chloride against carbon tetrachloride (CCl₄)-induced liver injury in rats. Manganese chloride (0.001, 0.01, 0.05 and 0.1 g/kg bw) was administered intragastrically for 28 consecutive days to male CCl₄-treated rats. The hepatoprotective activity was assessed using various biochemical parameters such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyltransferase (GGT) and superoxide dismutase (SOD). Histopathological changes in the liver of different groups were also studied. Administration of CCl₄ increased the serum ALT, AST, ALP and GGT but decreased SOD levels in rats. Treatment with manganese chloride significantly attenuated these changes to nearly normal levels. The animals treated with manganese chloride have shown decreased necrotic zones and hepatocellular degeneration when compared to the liver exposed to CCl₄ intoxication alone. Thus, the histopathalogical studies also supported the protective effect of manganese chloride. Therefore, the results of this study suggest that manganese chloride exerts hepatoprotection via promoting antioxidative properties against CCl₄-induced oxidative liver damage.     

菊花自交不亲和性初步研究

以菊花品种杂交为对照,通过自交亲和指数、受精作用及自交有性过程荧光显微镜观察,对菊花自交不亲和性进行了研究。结果表明:菊花自交难以结实,具不亲和性;菊花自交不亲和的反应部位在雌蕊柱头,表现为花粉粒粘附少、萌发率低及诱导胼胝质生成,花粉管在柱头上出现各种异常现象而难以进入花柱。     

海珠益肝胶囊对免疫性肝损伤模型小鼠的保护作用

目的：观察海珠益肝胶囊对卡介苗（BCG）加脂多糖（LPS）诱导的小鼠免疫性肝损伤的防护作用。方法：采用卡介苗（BCG）加脂多糖（LPS）诱导小鼠免疫性肝损伤,通过检测小鼠的血清谷丙转氨酶（ALT）和谷草转氨酶（AST）活性及肝脏病理变化来研究海珠益肝胶囊的保肝功能。结果：海珠益肝胶囊防治组小鼠血清ALT及AST活性比模型组显著降低,两组比较,差异有统计学意义。海珠益肝胶囊可明显减轻肝组织病理损伤,以大剂量组作用最佳;海珠益肝胶囊的使用使免疫性肝损伤小鼠肝细胞凋亡减少,且有剂量依赖关系。结论：海珠益肝胶囊对BCG加LPS诱导小鼠产生免疫性肝炎的模型免疫性肝损伤具有显著的保护作用。